Dhamasa Booti can remove the cancer problem(Purify the Blood circle)

 I conclude, on the basis of the beneficial effect of Fagonia arabica (Dhamasa) within the literature and our personal experimental results within the same herbal remedy, Fagonia arabica lyses blood clots in vitro; however, the soluble properties of vivo particles and the active component of Damascus clot lysis should be determined. Once Dhamasa is prescribed it can be combined as a thrombolytic agent in the development of patients suffering from Atherothrombotic disease. Competitive interests In conclusion, on the basis of the beneficial effect of Fagonia arabica (Dhamasa) within the literature and our personal experimental effects within the same herbal remedy, Fagonia arabica lyses blood clots in vitro; however, the soluble properties of vivo particles and the active component of Damascus clot lysis should be determined. Once Dhamasa is prescribed it can be combined as a thrombolytic agent in the development of patients suffering from Atherothrombotic disease.The in vitro thrombolytic version has been modified to test the effect of a mixture of six aquatic organic compounds namely, Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn next to -Streptokinase as an effective administration. and water as a misdemeanor.Using in vitro thrombolytic version, Tinospora cordifolia, Rubia cordifolia, Hemidesmus indicus, Glycyrrhiza glabra Linn, Fagonia Arabica and Bacopa monnieri Linn guaranteed 19.3%, 14.5 %, 20.3%, 7.8%, 17.8%, 17.8%, 17.8%, 17.8%. % won in sequence. Among the herbs studied, Fagonia arabica confirmed a significant percentage of clot lysis (75.6%) in the Streptokinase article (86.2%).

A blood clot (thrombus) emerged within the circulatory gut due to the failure of hemostasis to cause blockage of the arteries and at the same time when recovery ends in serious side effects of atherothrombotic diseases including myocardial or cerebral infarction, in cases leading to death [1]. Thrombolytic suppliers include tissue plasminogen activator (t-PA), Urokinase (UK), streptokinase (SK) etc. they are used everywhere in the world to treat those diseases. In India, aleven although SK and UK are widely used due to reduced cost, [2,3] compared to various thrombolytic drugs, their use is associated with a higher risk of bleeding [4] an excessive anaphylactic response and has no specificity . In addition, due to immunogenicity more than one herb with SK in a given person is limited [5]. Due to the deficiency of thrombolytic drugs, efforts are being made to increase the recombinant enhancement of these drugs [6 - 10]. Commercially available herbs, Tinospora cordifolia (guduchi), Rubia Cordifolia (manjistha), Hemidesmus indicus (Anantmoolh), Glycyrhiza, will be released. glabra Linn (traditional) Fagonia arabica (Damascus) and Baccopa monnieri (Linn) (brahmi) are purchased from Innocon Foods (Pune, India). The method of extracting more than one solvent (methanol: isopropyl alcohol: acetone) was modified to be used in a blended supplier. one hundred mg extract was converted into 10 ml of distilled water and the suspension changed vigorously in a vortex mixture. The suspension changed and was saved for one day and was terminated to eliminate the soluble supernatant, which turned into a filter with a 0.22-micron syringe filter. one hundred μl of this liquid training of altered herbs is inserted into microcentrifuge tubes containing clusters to test for thrombolytic activity.